Search

everythinglearnresearchcommunity

for

Search:↓

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

TA-Ado effectively promotes hair growth and reduces hair loss.

The scaffold effectively prevents melanoma relapse and aids wound healing.

The 3D printed scaffold with SB216763 and copper helps heal wounds and regrow skin and hair.

The N-K GM Series offers a free, effective solution to eliminate aflatoxin and cancer, improving health and life expectancy.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Sonidegib and vismodegib have different side effects and reporting patterns.

Doxazosin may cause breast enlargement and pain in men.

High-dose iron therapy improves anemia without affecting IBD treatment.

Mammograms are important for detecting breast cancer early.

Simple centrifugation with calcium gluconate boosts PDGF-BB release in PRP.

Injectable biomimetic gels can help heal tissues and deliver drugs but need improvements in strength and delivery.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Finasteride's solubility and bioavailability improved by forming solid dispersions and inclusion complexes.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Gold nanoclusters can improve detection, imaging, and therapy in medicine.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Liposome-composite hydrogel microspheres are promising for safe, controlled drug delivery.